Re-evaluation of myocardial FDG uptake in hyperglycemia

Area of Science:

• Nuclear Medicine
• Cardiovascular Physiology
• Metabolic Research

Background:

• Myocardial [18F] fluorodeoxyglucose (FDG) uptake is a key indicator of cardiac metabolism.
• Understanding factors influencing myocardial FDG uptake, such as blood glucose levels, is vital for accurate interpretation of Positron Emission Tomography (PET) imaging.

Purpose of the Study:

• To investigate the impact of experimentally induced hyperglycemia on myocardial FDG uptake in rats.
• To determine the relationship between varying serum glucose concentrations and myocardial FDG accumulation.

Main Methods:

• Young Donryu rats underwent intravenous injection of FDG.
• Hyperglycemia was induced using various agents (glucose, triiodothyronine, epinephrine, dehydroascorbic acid, streptozotocin, dexamethasone).
• Serum glucose, insulin, and free fatty acid levels were analyzed; myocardial FDG distribution was assessed via autoradiography.

Main Results:

• Myocardial FDG uptake increased proportionally with serum glucose levels up to 200 mg/dl.
• In severe hyperglycemia (200-450 mg/dl), FDG uptake decreased and showed no correlation with blood glucose.
• A similar biphasic uptake pattern was observed in skeletal muscles; insulin and free fatty acids did not explain the severe hyperglycemia findings.

Conclusions:

• Experimentally induced hyperglycemia exhibits a biphasic effect on myocardial FDG uptake in rats, mirroring patterns in skeletal muscle.
• This biphasic characteristic is important for interpreting myocardial FDG-PET imaging, especially in hyperglycemic states.